# The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)

> **NCT04941742** · — · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 71 (actual)

## Conditions studied

- Eosinophilic Esophagitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04941742
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-22
- **Primary completion:** 2021-12-22
- **Final completion:** 2021-12-22
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04941742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04941742, "The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04941742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*